Unknown NA INTERVENTIONAL NCT00103766

Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion

Randomized Comparison of Two Dose and Frequency Regimens of Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion

Sponsor: Genentech, Inc.

Conditions Empyema Pleural Effusion

Interventions Alteplase

Updated 5 times since 2017 Last updated: Jul 31, 2006 Started: Oct 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00103766, this NA trial focuses on Empyema and Pleural Effusion and remains ongoing. Sponsored by Genentech, Inc., it has been updated 5 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Genentech, Inc.
O'Brien, Jeana D., MD, FACP, FCCP
Scott and White Hospital & Clinic
Scott, Sherwood and Brindley Foundation
Texas A&M University

Data source: O'Brien, Jeana D., MD, FACP, FCCP

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Temple, United States